First Report of Prostate-specific Membrane Antigen-targeted Immunotherapy in Prostate Cancer: The Future is Bright.
Journal article
Lamb AD. et al, (2018), Eur urol, 73, 653 - 655
Orient Expression: Solving the Mystery of Asian Prostate Cancer?
Journal article
Lamb AD. et al, (2017), Eur urol
Systematic Review of Studies Reporting Positive Surgical Margins After Bladder Neck Sparing Radical Prostatectomy.
Journal article
Bellangino M. et al, (2017), Curr urol rep, 18
Reducing Mortality in the Ageing Patient: Treatment of the Primary Tumour Is Not Necessary.
Journal article
Lamb AD. et al, (2017), Eur urol focus, 3, 328 - 329
Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial.
Journal article
Johnston TJ. et al, (2017), Eur urol, 71, 381 - 388
Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144].
Journal article
Ross-Adams H. et al, (2017), Ebiomedicine, 17
Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Journal article
Lane A. et al, (2016), Bju int, 118, 869 - 879
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre.
Journal article
Gnanapragasam VJ. et al, (2016), Bju int, 118, 779 - 784
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer.
Journal article
Shaw GL. et al, (2016), Eur urol, 70, 214 - 218
Gene regulatory mechanisms underpinning prostate cancer susceptibility.
Journal article
Whitington T. et al, (2016), Nat genet, 48, 387 - 397
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
Journal article
Ross-Adams H. et al, (2015), Ebiomedicine, 2, 1133 - 1144
The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer.
Journal article
Sharma NL. et al, (2014), Nucleic acids res, 42, 6256 - 6269
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
Journal article
Ramos-Montoya A. et al, (2014), Embo molecular medicine, 6, 651 - 661
The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
Journal article
Sharma NL. et al, (2013), Cancer cell, 23, 35 - 47